تقرير
أعرض في EDS

Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report.

التفاصيل البيبلوغرافية
العنوان: Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report.
المؤلفون: Bhangu G; Department of Medicine, University of Calgary, Calgary, AB, Canada., Uminski K; Department of Medicine, University of Calgary, Calgary, AB, Canada.; Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program, Calgary, AB, Canada., Roessner C; Department of Medicine, University of Calgary, Calgary, AB, Canada.; Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program, Calgary, AB, Canada., Goodyear D; Department of Medicine, University of Calgary, Calgary, AB, Canada.; Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program, Calgary, AB, Canada., Sale T; Department of Medicine, University of Calgary, Calgary, AB, Canada.; Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program, Calgary, AB, Canada., Rydz N; Department of Medicine, University of Calgary, Calgary, AB, Canada. Natalia.rydz@albertahealthservices.ca.; Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program, Calgary, AB, Canada. Natalia.rydz@albertahealthservices.ca.; Division of Hematology & Hematological Malignancies, Room 681 Foothills Medical Centre, 1403 29th Street NW T2N 2T9, Calgary, AB, Canada. Natalia.rydz@albertahealthservices.ca.
المصدر: Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 3277-3279. Date of Electronic Publication: 2024 Apr 17.
نوع المنشور: Case Reports; Letter
اللغة: English
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
أسماء مطبوعة: Publication: Berlin : Springer Verlag
Original Publication: Berlin ; New York : Springer International, c1991-
مواضيع طبية MeSH: Hydroxyurea*/therapeutic use , Hydroxyurea*/adverse effects , Anemia, Sickle Cell*/complications , Anemia, Sickle Cell*/drug therapy , Gangrene*/etiology, Humans ; Male ; Antisickling Agents/therapeutic use ; Antisickling Agents/adverse effects ; Female ; Adult
References: Al Wahbi A (2018) Autoamputation of diabetic toe with dry gangrene: a myth or a fact? Diabetes Metab Syndr Obes 11:255–264. https://doi.org/10.2147/DMSO.S164199. (PMID: 10.2147/DMSO.S164199299106285987754)
Kumar B, Saraswat A, Kaur I (2002) Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. Clin Exp Dermatol 27(1):8–13. https://doi.org/10.1046/j.0307-6938.2001.00947.x. (PMID: 10.1046/j.0307-6938.2001.00947.x11952660)
Vassallo C, Passamonti F, Merante S, Ardigo M, Nolli G, Mangiacavalli S, Borroni G (2001) Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia. Clin Exp Dermatol 26(2):141–148. https://doi.org/10.1046/j.1365-2230.2001.00782.x. (PMID: 10.1046/j.1365-2230.2001.00782.x11298103)
Best PJ, Daoud MS, Pittelkow MR, Petitt RM (1998) Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med 128(1):29–32. https://doi.org/10.7326/0003-4819-128-1-199801010-00005. (PMID: 10.7326/0003-4819-128-1-199801010-000059424978)
Chaine B, Neonato MG, Girot R, Aractingi S (2001) Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. Arch Dermatol 137(4):467–470. (PMID: 11295927)
Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB (2008) Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 148(12):939–955. https://doi.org/10.7326/0003-4819-148-12-200806170-00221. (PMID: 10.7326/0003-4819-148-12-200806170-00221184582723256736)
Leo E, Kramer A, Hochhaus A, Krasniqi F, Hehlmann R, Ho AD (2002) Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy. Ann Hematol 81(8):467–469. https://doi.org/10.1007/s00277-002-0505-0. (PMID: 10.1007/s00277-002-0505-012224005)
Yasuda N, Ohmori S, Usui T (2000) Hydroxyurea-induced gangrene of the toes in a patient with chronic myelogenous leukemia. Am J Hematol 63(2):103–104. https://doi.org/10.1002/(sici)1096-8652(200002)63:2%3C103::aid-ajh11%3E3.0.co;2-n. (PMID: 10.1002/(sici)1096-8652(200002)63:2<103::aid-ajh11>3.0.co;2-n10629580)
Montefusco E, Alimena G, Gastaldi R, Carlesimo OA, Valesini G, Mandelli F (1986) Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia. Tumori 72(3):317–321. https://doi.org/10.1177/030089168607200314. (PMID: 10.1177/0300891686072003143488611)
Monfort JB, Senet P (2020) Leg Ulcers in Sickle-Cell Disease: treatment update. Adv Wound Care (New Rochelle) 9(6):348–356. https://doi.org/10.1089/wound.2018.0918. (PMID: 10.1089/wound.2018.091832286203)
Minniti CP, Kato GJ (2016) Critical reviews: how we treat sickle cell patients with leg ulcers. Am J Hematol 91(1):22–30. https://doi.org/10.1002/ajh.24134. (PMID: 10.1002/ajh.2413426257201)
Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S (2015) Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2015(6):CD004123. https://doi.org/10.1002/14651858.CD004123.pub4. (PMID: 10.1002/14651858.CD004123.pub4261068707055586)
المشرفين على المادة: X6Q56QN5QC (Hydroxyurea)
0 (Antisickling Agents)
تواريخ الأحداث: Date Created: 20240417 Date Completed: 20240728 Latest Revision: 20240728
رمز التحديث: 20240729
DOI: 10.1007/s00277-024-05732-w
PMID: 38630130
قاعدة البيانات: MEDLINE
الوصف
تدمد:1432-0584
DOI:10.1007/s00277-024-05732-w